Complications of gastrectomy following CPT-11 based neoadjuvant chemotherapy for gastric cancer

被引：1
|
作者：
Marcus, SG
Cohen, D
Lin, K
Wong, K
Thompson, S
Rothberger, A
Potmesil, M
Hiotis, S
Newman, E
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)83984-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A789 / A789
页数：1
相关论文
共 50 条
  • [21] Risk factors for surgical complications after D2 gastrectomy following neoadjuvant chemotherapy for gastric cancer.
    Yoshikawa, Takaki
    Aoyama, Toru
    Hayashi, Tsutomu
    Tanabe, Kazuaki
    Nishikawa, Kazuhiro
    Ito, Yuichi
    Cho, Haruhiko
    Morita, Satoshi
    Miyashita, Yumi
    Tsuburaya, Akira
    Sakamoto, Junichi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [22] Neoadjuvant radiochemotherapy with irinotecan (CPT-11) and capecitabine in locally advanced rectal cancer
    Kraus-Tiefenbacher, U
    Hofheinz, R
    von Gerstenberg-Heffdorf, B
    Willeke, F
    Hochhaus, A
    Wenz, F
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 31 - 31
  • [23] CPT-11 is an active agent in patients with advanced gastric cancer.
    Köhne, CH
    Catane, R
    Klein, H
    Peretz, T
    Preusser, P
    Niederle, N
    Ducreux, M
    Wilke, H
    Jacques, C
    CLINICAL CANCER RESEARCH, 1999, 5 : 3773S - 3773S
  • [24] Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer
    Abou-Taleb, Hisham A.
    Koshiyama, Masafumi
    Matsumura, Noriomi
    Baba, Tsukasa
    Yamaguchi, Ken
    Hamanishi, Junzo
    Abiko, Kaoru
    Yamanoi, Koji
    Murakami, Ryusuke
    Horikawa, Naoki
    Taha, Ahmed A. A.
    Kitamura, Sachiko
    Konishi, Ikuo
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2016, 44 (02) : 346 - 356
  • [25] Salvage chemotherapy with CPT-11 for recurrent glioblastoma multiforme
    Chamberlain, MC
    JOURNAL OF NEURO-ONCOLOGY, 2002, 56 (02) : 183 - 188
  • [26] Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following i.v. infusion of [14C]CPT-11 in cancer patients
    Slatter, JG
    Schaaf, LJ
    Sams, JP
    Feenstra, KL
    Johnson, MG
    Bombardt, PA
    Cathcart, KS
    Verburg, MT
    Pearson, LK
    Compton, LD
    Miller, LL
    Baker, DS
    Pesheck, CV
    Lord, RS
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (04) : 423 - 433
  • [27] CHEMOTHERAPY WITH CPT-11 AFTER GEMCITABINE FAILURE IN PATIENTS WITH ADVANCED PANCREATIC CANCER
    Kaneda, Hiroyasu
    Ueda, Shinya
    Makimura, Chihiro
    Kiyota, Hidemi
    Kawakami, Hisato
    Okamoto, Isamu
    Tanaka, Kaoru
    Nishina, Shinichi
    Kudo, Toshihiro
    Turutani, Junji
    Miyazaki, Masaki
    Fujisaka, Yasuhito
    Okamoto, Wataru
    Kurata, Takayasu
    Nakagawa, Kazuhiko
    ANNALS OF ONCOLOGY, 2012, 23 : 65 - 65
  • [28] Salvage Chemotherapy with CPT-11 for Recurrent Glioblastoma Multiforme
    Marc C. Chamberlain
    Journal of Neuro-Oncology, 2002, 56 : 183 - 188
  • [29] Nutritional modulation of the therapeutic index of CPT-11 chemotherapy
    Xue, H.
    Sawyer, M. B.
    Field, C. J.
    Dieleman, L. A.
    Baracos, V. E.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2006, 161 (03) : 210 - 210
  • [30] Neoadjuvant chemotherapy of CPT-11, 5-fluorouracil and leucovorin for T3/T4 rectal cancer
    Hasegawa, H
    Watanabe, M
    Nishibori, H
    Ochiai, H
    Kubota, T
    Kitajima, M
    Darzi, A
    BRITISH JOURNAL OF SURGERY, 2003, 90 : 135 - 135
12345